Monalizumab Biosimilar - Research Grade, Low Endotoxin

Monalizumab Biosimilar - Research Grade, Low Endotoxin

Catalog Number:
A001437401ICH
Mfr. No.:
ICH5017
Price:
$560
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Specificity: Detects human CD159a. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Monalizumab.
          Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
          Isotype Control: Bulk Human IgG4 Isotype Control (IB4) [ICH2257]
          Endotoxin: ≤ 1.0 EU/mg as determined by the LAL method

          Please contact us at for specific academic pricing.

          Background

          RUO monalizumab is a blocking antibody that prevents the inhibition of CD8+ T cells and NK cell by tumor cells expressing HLA-E. By acting simultaneously on innate and adaptive immunity, monalizumab may re-establish a broad anti-tumor response.

      • Properties
        • Isotype
          IgG4
          Reactivity
          human
          Purification
          >95% by SDS-PAGE
          Formulation
          Sterile, preservative-free, solution in PBS. BSA and Azide free.
          Storage
          This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
          Molecular Weight
          5mg/ml
          Antigen

          * Products are for research use only. Not for use in diagnostic or therapeutic procedures.

      • Applications
        • Application
          Functional Assays

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.